Genus Capital Management Inc. Makes New $2.32 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
3 Articles
3 Articles
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Cerity Partners LLC
Cerity Partners LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 252,924 shares of the pharmaceutical company’s stock after acquiring an additional 14,895 shares during the quarter. Cerity […]
Genus Capital Management Inc. Makes New $2.32 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Genus Capital Management Inc. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 1st quarter, Holdings Channel.com reports. The firm acquired 4,780 shares of the pharmaceutical company’s stock, valued at approximately $2,317,000. Several other institutional investors and hedge funds have also modified their holdings of VRTX. Mascagni Wealth […]
Diversify Wealth Management LLC Purchases 1,239 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Diversify Wealth Management LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 12.7% during the 1st quarter, HoldingsChannel.com reports. The fund owned 11,012 shares of the pharmaceutical company’s stock after acquiring an additional 1,239 shares during the period. Diversify Wealth Management LLC’s holdings in Vertex Pharmaceuticals were worth $5,544,000 […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium